Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes have?
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has 6,751 citations in the OpenAlex counts ScholarIQ stores.
When was Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes published?
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has 2016 year in the ScholarIQ index.
What is the open-access status of Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
The DOI for Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is on the source record.
What is the PMID of Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
The PMID for Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is on the source record.
What is the OpenAlex record for Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
The OpenAlex for Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is on the source record.